Actionnariat et activité des initiés pour Amicus Therapeutics, Inc. (FOLD): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $14.49 |
| Capitalisation | $4.5B |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-04-27 | WHEELER CRAIG A | D-Return | 84,631 | $1.2M |
| 2026-04-27 | WHEELER CRAIG A | D-Return | 30,000 | $201K |
| 2026-04-27 | WHEELER CRAIG A | D-Return | 16,236 | $140K |
| 2026-04-27 | WHEELER CRAIG A | D-Return | 19,473 | $234K |
| 2026-04-27 | WHEELER CRAIG A | D-Return | 18,574 | $238K |
| 2026-04-27 | WHEELER CRAIG A | D-Return | 36,111 | $387K |
| 2026-04-27 | WHEELER CRAIG A | D-Return | 45,423 | $388K |
| 2026-04-27 | WHEELER CRAIG A | D-Return | 30,474 | $385K |
| 2026-04-27 | WHEELER CRAIG A | D-Return | 42,467 | $436K |
| 2026-04-27 | WHEELER CRAIG A | D-Return | 74,872 | $446K |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $187.0M | $49.1M | $79.7M | $142.8M | $163.2M | $245.2M | $148.8M | $247.0M | $213.8M | $214.0M |
| Placements à Court Terme | $143.3M | $309.5M | $424.4M | $309.9M | $320.0M | $237.3M | $144.8M | $39.2M | $36.2M | $79.5M |
| Créances | $1.3M | $9.5M | $22.0M | $33.3M | $46.9M | $52.7M | $66.2M | $87.6M | $101.1M | $115.3M |
| Stocks | $3.4M | $4.6M | $8.4M | $14.0M | $19.6M | $26.8M | $23.8M | $59.7M | $118.8M | $228.8M |
| Actifs Courants | $340.1M | $392.0M | $551.1M | $520.1M | $579.5M | $596.8M | $423.8M | $483.1M | $504.7M | $676.2M |
| Immobilisations Corporelles | $9.8M | $9.1M | $11.4M | $81.0M | $67.2M | $63.1M | $60.3M | $58.0M | $51.7M | $48.2M |
| Goodwill | $197.8M | $197.8M | $197.8M | $197.8M | $197.8M | $197.8M | $197.8M | $197.8M | $197.8M | $197.8M |
| Actifs Incorporels | $486.7M | $23.0M | $23.0M | $23.0M | $23.0M | $23.0M | $23.0M | $20.5M | $17.2M | $13.9M |
| Actifs Totaux | $1.04B | $627.0M | $790.0M | $850.2M | $886.5M | $905.1M | $724.2M | $777.9M | $785.0M | $949.9M |
| Dettes Fournisseurs | $12.9M | $7.9M | $6.6M | $21.7M | $17.1M | $21.5M | $15.4M | $15.1M | $12.9M | $28.6M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $8.7M |
| Passifs Courants | $111.0M | $70.0M | $86.1M | $128.8M | $129.7M | $146.0M | $139.0M | $167.7M | $148.7M | $237.8M |
| Dette à Long Terme | $154.5M | $164.2M | $321.7M | $149.5M | $389.3M | $389.4M | $392.0M | $387.9M | $390.1M | $433.6M |
| Passifs Totaux | $676.7M | $274.2M | $447.0M | $373.8M | $600.1M | $597.8M | $601.1M | $617.7M | $591.0M | $675.6M |
| Réserves | -$779.6M | -$1.06B | -$1.41B | -$1.77B | -$2.05B | -$2.30B | -$2.53B | -$2.68B | -$2.74B | -$2.77B |
| Capitaux Propres | $360.2M | $352.9M | $342.9M | $476.4M | $286.4M | $307.4M | $123.0M | $160.2M | $194.0M | $274.2M |
| Dette Totale | $154.5M | $164.5M | $321.7M | $210.2M | $441.7M | $440.1M | $452.1M | $445.1M | $443.6M | $483.3M |
| Dette Nette | -$175.9M | -$194.1M | -$182.4M | -$242.5M | -$41.5M | -$42.4M | $158.5M | $158.9M | $193.7M | $189.8M |
| Fonds de Roulement | $229.1M | $321.9M | $465.0M | $391.3M | $449.8M | $450.9M | $284.8M | $315.4M | $356.0M | $438.3M |
Santé financière
| Dette / Capitaux propres | 1.76 |
| Ratio de liquidité | 2.84 |
Rentabilité
| Marge brute | 87.91% |
| Marge opérationnelle | 5.17% |
| Marge nette | -4.27% |
Entreprises liées: ADPT · ARQT · CDTX · CPRX · IDYA · KNSA · LEGN
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de FOLD: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions